Financing, Equity Capital Markets
CymaBay Therapeutics, Inc.
01/23
|
$97.7 Million
![](/sites/default/files/images/custom/cymabay-therapeutics-inc_0.png)
Piper Sandler served as left bookrunner for Cymabay Therapeutics, Inc. on a confidentially marketed follow-on offering